The USFDA has done the audit of Cadila Healthcare’s facility based at Ankleshwar in Gujarat. The facility is involved in the manufacturing of active pharmaceutical ingredients.
The USFDA inspection was carried out in between 22 July to 26 July. The inspection was successfully completed with zero obserevation.
Both, Unit 1 and Unit 2 were involved in the USFDA inspection.
Copyright © 2021 Institute of Good Manufacturing Practices India ( IGMPI® All Rights Reserved. Trademarks are the property of the owner )